Choroidal Neovascular Membrane,
Showing 51 - 75 of 3,017
Angioid Streaks of Macula Trial in Mykolaiv, Odessa (Intravitreal injection)
Recruiting
- Angioid Streaks of Macula
- Intravitreal injection
-
Mykolaiv, Ukraine
- +2 more
Feb 2, 2021
Rate of Pseudoxanthoma Elasticum-associated Choroidal and
Recruiting
- Pseudoxanthoma Elasticum
- No intervention
-
Basel, Basel-Stadt, SwitzerlandUniversity Hospital Basel
Dec 21, 2022
Neovascular Age-related Macular Degeneration Trial in Worldwide (brolucizumab)
Active, not recruiting
- Neovascular Age-related Macular Degeneration
-
Huntington Beach, California
- +59 more
Jan 20, 2023
Macular Degeneration Trial in Worldwide (Ranibizumab)
Completed
- Macular Degeneration
- Ranibizumab
-
Gilbert, Arizona
- +101 more
Mar 11, 2022
Macular Degeneration Trial in United Kingdom (Epimacular Brachytherapy, Ranibizumab)
Completed
- Macular Degeneration
- Epimacular Brachytherapy
- Ranibizumab
-
Exeter, Devon, United Kingdom
- +23 more
Nov 23, 2020
Neovascular Age-Related Macular Degeneration, Choroidal Neovascularization Trial in Fort Worth (Brolucizumab ophthalmic
Completed
- Neovascular Age-Related Macular Degeneration
- Choroidal Neovascularization
- Brolucizumab ophthalmic solution
- Aflibercept ophthalmic solution
-
Fort Worth, TexasContact Alcon Call Center for Trial Locations
Jan 8, 2020
Age-related Macular Degeneration, Macular Degeneration, Wet Macular Degeneration Trial in Germany, Switzerland (Brolucizumab)
Recruiting
- Age-related Macular Degeneration
- +5 more
- Brolucizumab
-
Regensburg, Bavaria, Germany
- +32 more
Jan 20, 2023
Neovascular Macular Degeneration Trial in Worldwide (Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321), Visudyne)
Completed
- Neovascular Macular Degeneration
- Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
- Visudyne
-
Liverpool, New South Wales, Australia
- +61 more
Nov 17, 2020
Patients Receiving Beovu in Neovascular Age-related Macular
Recruiting
- Neovascular Age-related Macular Degeneration (nAMD)
-
Luedenscheid, NRW, Germany
- +48 more
Sep 16, 2022
Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)
Recruiting
- Neovascular Age-related Macular Degeneration
- ADVM-022
-
Phoenix, Arizona
- +4 more
Sep 8, 2022
Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]
Enrolling by invitation
- Wet Age-related Macular Degeneration
- Neovascular Age-related Macular Degeneration
- ADVM-022
-
Bakersfield, California
- +8 more
Dec 23, 2021
Choroidal Thickness Vitrectomy
Completed
- Epiretinal Membrane
-
Vienna, AustriaDepartment of Ophthalmology, Medical University of Vienna, Austr
Oct 15, 2019
Corneal Transplantation, Glaucoma and Ocular Hypertension, Postoperative Complications Trial in Montréal (Boston
Recruiting
- Corneal Transplantation
- +4 more
- Boston keratoprosthesis type 1 and anterior hyaloid membrane peeling assisted by endoscopy
-
Montréal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal (CHUM)
Jul 4, 2022
Neovascular Age-Related Macular Degeneration Trial in United States (PDS Implant filled with 100 mg/mL Ranibizumab, Intravitreal
Completed
- Neovascular Age-Related Macular Degeneration
- PDS Implant filled with 100 mg/mL Ranibizumab
- Intravitreal Injections of 10 mg/mL Ranibizumab
-
Mesa, Arizona
- +76 more
Feb 28, 2022
Neovascular Age-related Macular Degeneration Trial (PMC-403)
Not yet recruiting
- Neovascular Age-related Macular Degeneration
- (no location specified)
Jul 11, 2023
Wet Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)
Active, not recruiting
- Wet Age-related Macular Degeneration
- Neovascular Age-related Macular Degeneration
- ADVM-022
-
Bakersfield, California
- +10 more
Mar 21, 2022
Neovascular Age-related Macular Degeneration Trial in Worldwide (SOK583A1 (40 mg/mL), Eylea EU (40 mg/mL))
Active, not recruiting
- Neovascular Age-related Macular Degeneration
- SOK583A1 (40 mg/mL)
- Eylea EU (40 mg/mL)
-
Phoenix, Arizona
- +101 more
Jan 23, 2023
Diabetes, Type 2, Diabetic Retinopathy Trial (RLRL device)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Diabetic Retinopathy
- RLRL device
- (no location specified)
Mar 19, 2023
Choroidal Melanoma Trial in Aurora (1000CsK Silicon Oil Tamponade)
Completed
- Choroidal Melanoma
- 1000CsK Silicon Oil Tamponade
-
Aurora, ColoradoUniversity of Colorado Eye Center
Mar 4, 2022
Myopia, Myopia Progression, Juvenile Myopia Trial in Waterloo (Diffusion Optics Technology (DOT) Pattern Spectacle Lens, Control
Not yet recruiting
- Myopia
- +2 more
- Diffusion Optics Technology (DOT) Pattern Spectacle Lens
- Control Spectacle Lens
-
Waterloo, Ontario, CanadaCentre for Ocular Research and Education
Dec 5, 2022
Neovascular Age-related Macular Degeneration Trial in United States (OLX10212 is a cell penetrating asymmetric small
Recruiting
- Neovascular Age-related Macular Degeneration
- OLX10212 is a cell penetrating asymmetric small interference RNA (cp-asiRNA)
-
Santa Maria, California
- +4 more
Jan 10, 2023
Neovascular Age-related Macular Degeneration Trial in Seongnam-si (Probiotic Combination Cap/Tab, intravitreal Anti-VEGF
Recruiting
- Neovascular Age-related Macular Degeneration
- Probiotic Combination Cap/Tab
- intravitreal Anti-VEGF injection
-
Seongnam-si, Korea, Republic ofSeoul National University Bundang Hospital
Nov 1, 2022
Neovascular Age-related Macular Degeneration Trial in Worldwide (2.0 mg OPT-302, 2.0 aflibercept, Sham)
Recruiting
- Neovascular Age-related Macular Degeneration
- 2.0 mg OPT-302
- +2 more
-
Phoenix, Arizona
- +182 more
Sep 6, 2022
Neovascular Age-related Macular Degeneration Trial in Worldwide (2.0 mg OPT-302, 0.5 mg ranibizumab, Sham)
Recruiting
- Neovascular Age-related Macular Degeneration
- 2.0 mg OPT-302
- +2 more
-
Phoenix, Arizona
- +174 more
Sep 6, 2022